A detailed history of National Bank Of Canada transactions in Dexcom Inc stock. As of the latest transaction made, National Bank Of Canada holds 286,955 shares of DXCM stock, worth $23 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
286,955
Previous 286,955 -0.0%
Holding current value
$23 Million
Previous $19.2 Million -0.0%
% of portfolio
0.03%
Previous 0.03%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$64.0 - $116.06 $5.3 Million - $9.61 Million
82,834 Added 40.58%
286,955 $19.2 Million
Q2 2024

Aug 02, 2024

SELL
$110.31 - $140.45 $1.17 Million - $1.49 Million
-10,644 Reduced 4.96%
204,121 $23.1 Million
Q1 2024

May 13, 2024

SELL
$114.22 - $140.1 $14.4 Million - $17.7 Million
-125,992 Reduced 36.97%
214,765 $29.8 Million
Q4 2023

Feb 06, 2024

SELL
$75.49 - $124.16 $8.21 Million - $13.5 Million
-108,781 Reduced 24.2%
340,757 $42.3 Million
Q3 2023

Oct 10, 2023

BUY
$86.06 - $137.93 $20 Million - $32.1 Million
232,604 Added 107.22%
449,538 $41.9 Million
Q2 2023

Jul 26, 2023

BUY
$112.47 - $130.98 $19.3 Million - $22.4 Million
171,390 Added 376.32%
216,934 $27.9 Million
Q1 2023

Apr 12, 2023

BUY
$104.0 - $122.92 $1.08 Million - $1.28 Million
10,417 Added 29.66%
45,544 $5.29 Million
Q4 2022

Jan 24, 2023

BUY
$84.98 - $122.67 $2.81 Million - $4.06 Million
33,086 Added 1621.07%
35,127 $0
Q3 2022

Oct 13, 2022

SELL
$76.35 - $94.18 $8,551 - $10,548
-112 Reduced 5.2%
2,041 $165,000
Q2 2022

Jul 28, 2022

BUY
$67.99 - $132.89 $109,395 - $213,820
1,609 Added 295.77%
2,153 $160,000
Q1 2022

May 05, 2022

SELL
$94.08 - $130.2 $33,868 - $46,871
-360 Reduced 39.82%
544 $278,000
Q4 2021

Jan 24, 2022

BUY
$129.87 - $162.82 $117,402 - $147,189
904 New
904 $486,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $31B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track National Bank Of Canada Portfolio

Follow National Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of National Bank Of Canada , based on Form 13F filings with the SEC.

News

Stay updated on National Bank Of Canada with notifications on news.